معرفی
Associate Professor Philip Ahring is a neuroscientist affiliated with the University of Sydney's Faculty of Medicine and Health, and a member of the Brain and Mind Centre. His research focuses on ion channel biology, particularly GABA-A receptors and nicotinic acetylcholine receptors, with emphasis on their roles in epilepsy, neurodevelopmental disorders, and neurological drug discovery. He has contributed to understanding genotype-phenotype relationships in epilepsy through functional analysis of genetic variants and has pioneered studies on receptor pharmacology and therapeutic modulation.
Key research areas include:
- Mechanisms of GABAergic and cholinergic receptor dysfunction in neurological diseases
- Pharmacological characterization of receptor subunit variants
- Development of novel therapeutic strategies targeting ion channels
- Structure-function relationships in neurotransmitter receptors
Recent work includes identifying pathogenic mechanisms in GABRB2, GABRD, and GABRA4 variants linked to epilepsy, and demonstrating therapeutic potential of compounds like vinpocetine for GABRA1-related disorders. He has secured grants including the 2024 FMH Rewarding Research Award and NHMRC grants for precision medicine initiatives.
Collaborations span academic and industry partners, with notable contributions to drug discovery programs targeting nicotinic receptors and GABA-A subunit modulators. His lab's work bridges basic neuroscience with clinical translation, aiming to advance therapies for epilepsy and neurodegenerative conditions.
